{
    "id": 80367,
    "name": "chronic eosinophilic leukemia",
    "source": "DOID",
    "definition": "A chronic leukemia characterized by a clonal proliferation of eosinophilic precursors resulting in persistently increased numbers of eosinophils in the blood, marrow and peripheral tissues. [url:https\\://ghr.nlm.nih.gov/condition/pdgfra-associated-chronic-eosinophilic-leukemia, url:https\\://www.cancer.gov/publications/dictionaries/cancer-terms/def/chronic-eosinophilic-leukemia]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:0080367",
    "evidence": [
        {
            "id": 16973,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with chronic eosinophilic leukemia harboring PCM1-JAK2 demonstrated complete clinical remission and decreased fusion transcript levels when treated with Jakafi (ruxolitinib) (PMID: 23630205).",
            "molecularProfile": {
                "id": 23864,
                "profileName": "PCM1 - JAK2"
            },
            "therapy": {
                "id": 907,
                "therapyName": "Ruxolitinib",
                "synonyms": null
            },
            "indication": {
                "id": 80367,
                "name": "chronic eosinophilic leukemia",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 15124,
                    "pubMedId": 23630205,
                    "title": "Efficacy of ruxolitinib in chronic eosinophilic leukemia associated with a PCM1-JAK2 fusion gene.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23630205"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT03801434",
            "title": "Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders",
            "phase": "Phase II",
            "recruitment": "Not yet recruiting",
            "therapies": [
                {
                    "id": 907,
                    "therapyName": "Ruxolitinib",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03862157",
            "title": "Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia",
            "phase": "Phase Ib/II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 7993,
                    "therapyName": "Azacitidine + MLN4924 + Venetoclax",
                    "synonyms": null
                }
            ]
        }
    ]
}